Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Release of Journal of Neurosurgery 10-Year Study by Dr. Todd Lanman Shows Statistical Superiority of Two-Level Cervical Disc Replacement with Prestige LP Device
  • USA - English

Ten-year follow-up data indicates discs next to fusion required surgery twice as often as discs next to artificial discs.


News provided by

Dr. Todd Lanman

Oct 23, 2019, 17:00 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Oct. 23, 2019 /PRNewswire-PRWeb/ -- In a new study, authored by Dr. Todd H. Lanman and Matthew F. Gornet, MD, and published in the prominent peer-reviewed medical journal Journal of Neurosurgery, two-level cervical disc replacement with the Prestige LP continues to maintain statistical superiority a decade following surgery.

The 10-year paper follows the previously published 7-year outcome, which found statistical superiority compared to that of fusion, in treating degenerative disc disease in two adjacent disc levels, and the initial 24-month study documenting 'favorable outcomes' at the two-year post-op mark.

The most compelling data from the 10-year follow-up is that the discs next to the fusion required surgery twice as often as discs adjacent to the artificial discs.

This is the second time that this groundbreaking procedure, led by Dr. Lanman as principal investigator of the initial clinical trial, has been found to be a statistically superior option for patients suffering from cervical degenerative disc disease in more than one level in their neck.

In addition to Lanman and Gornet, as lead writer, the paper was also authored by J. Kenneth Burkus, MD, Randall G. Dryer, MD, Jeffrey R. McConnell, MD, Scott D. Hodges, DO, and F.W. Schranck.

The authors all assessed the 10-year clinical safety and effectiveness of cervical disc arthroplasty to treat degenerative disease in the cervical spine at two adjacent levels compared to anterior cervical discectomy and fusion (ACDF).

The clinical trial was conducted comparing the low-profile titanium ceramic composite-based Prestige LP artificial disc replacement device at two adjacent levels of the cervical spine with ACDF. From the 24-month to the 10-year mark, replacement at two adjacent levels with implantation of the Prestige LP demonstrated statistical superiority over ACDF for overall success with rates of 80.4% to that of 62.2% at 10 years.

The study also found statistical superiority when comparing results of the Neck Disability Index (88.4% versus 76.5%), neurological success (92.6% versus 86.1%) and neck pain scores.

Through this prospective, randomized, controlled, multicenter FDA-approved study, the Prestige LP, implanted at two adjacent cervical disc levels, was found to maintain 'improved clinical outcomes and segmental motion 10 years after surgery and is a safe and effective alternative to fusion,' as the paper concludes.

This procedure now gives patients suffering from multilevel degenerative disc disease in their cervical spines an alternative to statistically inferior ACDF, or fusion surgery, which often places additional stress on adjacent discs, leading to pain and additional surgical procedures, as well as much longer recovery time. Artificial disc replacement in the cervical spine in one or two levels is approved by most insurance plans.

In 2017, Dr. Lanman showcased the first two-level procedure using a Prestige LP artificial cervical disc device on national television, performing the surgery on a patient on CBS' 'The Doctors.'

Dr. Lanman has been referred to as one of the nation's leading innovators in artificial disc replacement, presiding over the majority of major advancements in spine care over the last 25 years. He's the first spinal neurosurgeon in the U.S. to pioneer what he refers to as Restorative Motion Surgery, a breakthrough procedure that returns patients who had undergone fusion to near or full mobility and motion, by removing those fusions and instead replacing them with artificial disc devices in one or more levels.

In 2018, he was named the 'Leader in Health Care' by the Los Angeles Business Journal, earning an award for this honor, and has been dubbed one of the top doctors in this field in The Los Angeles Times, The Hollywood Reporter and Hemispheres Magazine.

Major celebrities from the worlds of television, film and Broadway, as well as business tycoons and sports players constitute a significant portion of his patients, as well as those coming from overseas for his unparalleled care.

He has remained a clinical professor at UCLA for the last 20 years, has published a wealth of peer-reviewed articles and book chapters relating to spine medicine, and serves as a frequent medical educator and expert contributor in the media.

The new 10-year study paper can be found here: https://www.ncbi.nlm.nih.gov/pubmed/31226684.

For more information on Dr. Todd H. Lanman and his Beverly Hills-based practice Lanman Spinal Neurosurgery, visit http://www.spine.md.

SOURCE Dr. Todd Lanman

Related Links

http://www.spine.md

Modal title

Dr. Todd H. Lanman, Lanman Spinal Neurosurgery
Dr. Todd H. Lanman, Lanman Spinal Neurosurgery
Dr. Todd H. Lanman, Lanman Spinal Neurosurgery

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.